Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
01 2Biophore India Pharmaceuticals Pvt Ltd
02 1ANDA Repository
03 1Amphastar Pharmaceuticals
04 1Annora Pharma
05 13Bayer AG
06 15Bracco
07 6GE Healthcare Inc
08 3Grupo Juste
09 1Iberoinvesa Pharma Sl
10 2Jodas Expoim Pvt. Ltd
11 4Mallinckrodt Pharmaceuticals
12 1Xian Libang Pharmaceutical Co.,Ltd
01 1Diatrizoico Acid 370Mg Iodine/Ml 100Ml Oral Or Rectal Administration
02 22INJECTABLE;INJECTION
03 1Injectable Solution
04 5Injection
05 1LIQ
06 1Melange/rectal fluid, resolution
07 3Oral And Rectal Solution
08 1Oral Solution/Rectal Solution
09 1SOLUTION
10 1SOLUTION;INTRAUTERINE
11 5SOLUTION;ORAL, RECTAL
12 3SOLUTION;URETERAL
13 3SOLUTION;URETHRAL
14 1Solution For Injection
15 1Solution For Injection And Infusion
01 1Allowed
02 6Authorized
03 28DISCN
04 1Ethical
05 2Generic
06 1Originator
07 6RX
08 5Blank
01 1ANGIOVIST 282
02 1ANGIOVIST 292
03 1ANGIOVIST 370
04 1Amidotrizoato De Sodio Y Amidotrizoato De Meglumina Iberoinvesa Pharma
05 1CARDIOGRAFIN
06 1CYSTOGRAFIN
07 1CYSTOGRAFIN DILUTE
08 1DIATRIZOATE MEGLUMINE
09 2DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
10 1DIATRIZOATE-60
11 2GASTROGRAFIN
12 1GASTROVIST
13 5Gastrografin
14 1Gastrolux
15 2HYPAQUE
16 1HYPAQUE-76
17 1HYPAQUE-CYSTO
18 1HYPAQUE-M,75%
19 1HYPAQUE-M,90%
20 1MD-60
21 1MD-76
22 1MD-76R
23 1MD-GASTROVIEW
24 1Plenigraf
25 1RENO-30
26 1RENO-60
27 1RENO-DIP
28 1RENOCAL-76
29 1RENOGRAFIN-60
30 1RENOGRAFIN-76
31 1RENOVIST
32 1RENOVIST II
33 1Radialar
34 1SINOGRAFIN
35 1UROVIST CYSTO
36 1UROVIST CYSTO PEDIATRIC
37 1UROVIST MEGLUMINE DIU/CT
38 1Urografin
39 5Blank
01 1Canada
02 1China
03 4India
04 1Italy
05 1Norway
06 1South Africa
07 6Spain
08 1Switzerland
09 34USA
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 60%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Diatrizoate Sodium; Diatrizoate Meglumine
Brand Name :
Dosage Form : Injection
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOGRAFIN-76
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOGRAFIN-60
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 52%;8%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RENO-DIP
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 30%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RENO-60
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 60%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DIATRIZOATE MEGLUMINE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 76%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CYSTOGRAFIN
Dosage Form : SOLUTION;URETHRAL
Dosage Strength : 30%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOVIST II
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 28.5%;29.1%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : RENOVIST
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 34.3%;35%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RENO-30
Dosage Form : SOLUTION;URETERAL
Dosage Strength : 30%
Packaging :
Approval Date : 1982-01-01
Application Number : 10040
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CYSTOGRAFIN DILUTE
Dosage Form : SOLUTION;URETHRAL
Dosage Strength : 18%
Packaging :
Approval Date : 1982-11-09
Application Number : 10040
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : GASTROGRAFIN
Dosage Form : SOLUTION;ORAL, RECTAL
Dosage Strength : 66%;10%
Packaging :
Approval Date : 1982-01-01
Application Number : 11245
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; IODIPAMIDE MEGLUMINE
Brand Name : SINOGRAFIN
Dosage Form : SOLUTION;INTRAUTERINE
Dosage Strength : 52.7%;26.8%
Packaging :
Approval Date : 1982-01-01
Application Number : 11324
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CARDIOGRAFIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 85%
Packaging :
Approval Date : 1982-01-01
Application Number : 11620
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : HYPAQUE-M,90%
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 60%;30%
Packaging :
Approval Date : 1982-01-01
Application Number : 10220
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Brand Name : HYPAQUE-M,75%
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 50%;25%
Packaging :
Approval Date : 1982-01-01
Application Number : 10220
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 60%
Packaging :
Approval Date : 1982-01-01
Application Number : 16403
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 30%
Packaging :
Approval Date : 1982-01-01
Application Number : 16403
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : HYPAQUE-CYSTO
Dosage Form : SOLUTION;URETHRAL
Dosage Strength : 30%
Packaging :
Approval Date : 1982-01-01
Application Number : 16403
Regulatory Info : DISCN
Registration Country : USA
